Recognition and prevention of hospital-associated enteric infections in the intensive care unit

Critical Care Medicine

Volumn 38, Issue 8 SUPPL., 2010, Pages

  Bobo, Linda D ^a   Dubberke, Erik R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clostridium difficile; control; fulminant colitis; hospital associated diarrhea; intensive care unit; norovirus; prevention; pseudo outbreak; rotavirus

Indexed keywords

GLUTAMATE DEHYDROGENASE;

ANTIMICROBIAL STEWARDSHIP PROGRAM; BACTERIAL TRANSMISSION; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COST EFFECTIVENESS ANALYSIS; CRYPTOSPORIDIUM; DISEASE SEVERITY; ENVIRONMENTAL SANITATION; ENZYME IMMUNOASSAY; FECES CULTURE; GIARDIA LAMBLIA; HAND WASHING; HEALTH PROGRAM; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFECTIOUS DIARRHEA; INTENSIVE CARE UNIT; NOROVIRUS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SALMONELLA ENTERICA; SENSITIVITY AND SPECIFICITY;

EID: 77954942080     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181e69f05     Document Type: Article

References (146)

1. Kelly TWJ, Patrick MR, Hillman KM: Study of diarrhea in critically ill patients. Crit Care Med 1983; 11:7-9
2. Thakkar K, Kien CL, Rosenblatt JI, et al: Diarrhea in severely burned children. J Par-enter Enteral Nutr 2005; 29:8-11
3. Farr BM: Nosocomial gastrointestinal tract infections. In: Hospital Epidemiology and Infection Control. Third Edition. Mayhall GC (Ed). Philadelphia, Lippincott Williams and Wilkins, 2004, pp 351-383
4. Stamm WE, Weinstein RA, Dixon RE: Comparison of endemic and epidemic nosoco-mial infections. Am J Med 1981; 70:393-397
5. Walters BA, Stafford R, Roberts RK, et al: Contamination and cross infection with C. difficile in an intensive care unit. Aust N Z J Med 1982; 12:255
6. Foulke GE, Silva J: Clostridium difficile in the intensive care unit: Management problems and prevention issues. Crit Care Med 1989; 17:822-826
7. Singh-Naz N, Sprague BM, Patel KM, et al: Risk factors for nosocomial infection in critically ill children: A prospective cohort study. Crit Care Med 1996; 24:875-878
8. Archibald LK, Banerjee SN, Jarvis WR: Secular trends in hospital-acquired Clostrid-ium difficile disease in the United States, 1987-2001. J Infect Dis 2004; 189: 1585-1589
9. Guallar C, Ariza J, Dominguez A, et al: An insidious nosocomial outbreak due to Salmonella enteritidis. Infect Control Hosp Epidemiol 2004; 25:10-15
10. Ang CW, Heyes G, Morrison P, et al: The acquisition and outcome of ICU-acquired Clostridium difficile infection in a single centre in the UK. J Infect 2008; 57:435-440
11. Sommer C, Mueller W, Resch B: Two nos-ocomial norovirus outbreaks in the neonatal intensive and intermediate care unit. Eur J Clin Microbiol Infect Dis 2009; 28: 1133-1136
12. Siegel JD, Rhinehart E, Jackson M, et al: 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Surveillance. Atlanta, Centers for Disease Control and Prevention, 2007
13. Farr BM: Nosocomial gastrointestinal tract infections. In: Hospital Epidemiology and Infection Control. Third Edition. Mayhall GC (Ed). Philadelphia, Lippincott Williams and Wilkins, 2004
14. Centers for Disease Control and Prevention (CDC): Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food-10 states, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:333-337
15. Gleizes O, Desselberger U, Tatochenko V, et al: Nosocomial rotavirus infection in European countries: A review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 2006; 25:S12-S21
16. Aho LS, Simon I, Bour JB, et al: Epidemiology of viral nosocomial infections in pediatrics. Pathol Biol (Paris) 2000; 48: 885-892
17. Ford-Jones EL, Mindorff CM, Gold R, et al: The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am J Epidemiol 1990; 131:711-718
18. Hardy DB: Epidemiology of rotavirus infection in adults. Rev Infect Dis 1987; 9:461-469
19. Johnston CP, Qiu H, Ticehurst JR, et al: Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis 2007; 45:534-540
20. Wilcox M, Fawley W: Viral gastroenteritis increases the reports of Clostridium difficile infection. J Hosp Infect 2007; 66:395-396
21. Barrett SP, Holmes AH, Newsholme WA, et al: Increased detection of Clostridium difficile during a norovirus outbreak. J Hosp Infect 2007; 66:394-395
22. Bignardi GE, Staples K, Majmudar N: A case of norovirus and Clostridium difficile infection: Casual or causal? J Hosp Infect 2007; 67:198-200
23. Fan K, Morris AJ, Reller LB: Application of rejection criteria for stool cultures for bacterial enteric pathogens. J Clin Microbiol 1993; 31:2233-2235
24. Bauer TM, Lalvani A, Fehrenbach J, et al: Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA 2001; 285:313-319
25. Valenstein P, Pfaller M, Yungbluth M: The use and abuse of routine stool microbiology: A College of American Pathologists Q-probes study of 601 institutions. Arch Pathol Lab Med 1996; 120:206-211
26. Seyler L, Lalvani A, Collins L, et al: Safety and cost savings of an improved three-day rule for stool culture in hospitalized children and adults. J Hosp Infect 2007; 67: 121-126
27. Pothoulakis C, Sullivan R, Melnick DA, et al: Clostridium difficile toxin A stimulates intracellular calcium release and chemotac-tic response in human granulocytes. J Clin Invest 1988; 81:1741-1745
28. Riegler M, Sedivy R, Pothoulakis C, et al: Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 1995; 95: 2004-2011
29. Voth DE, Ballard JD: Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005; 18: 247-263
30. Hall I, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935; 49:390-402
31. Tedesco FJ, Stanley RJ, Alpar DH: Diagnostic features of clindamycin-associated pseudomembranous colitis. N Engl J Med 1974; 290:841-843
32. Bartlett JG, Chang TW, Gurwith M, et al: Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978; 298:531-534 (Pubitemid 8295586)
33. Rotimi VO, Mokaddas EM, Jamal WY, et al: Hospital-acquired Clostridium difficile infection amongst ICU and burn patients in Kuwait. Med Princ Pract 2002; 11:23-28
34. Rotimi VO, Jamal WY, Mokaddas EM, et al: Prevalent PCR ribotypes of clinical and environmental strains of Clostridium difficile isolated from intensive-therapy unit patients in Kuwait. J Med Microbiol 2003; 52:705-708
35. Barrington A, Borriello SP, Brazier J, et al: National Clostridium difficile Standards Group: Report to the Department of Health. J Hosp Infect 2004; 56:1-38
36. Zilberberg MD: Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis 2009; 15:122-124
37. Agency for Healthcare Research and Quality: HCUPnet. Rockville (MD): The Agency [cited 2007 Oct 1]. Available at http://hcupnet.ahrq.gov. Accessed June 1, 2008
38. Jarvis WR, Schlosser J, Jarvis AA, et al: National point prevalence of Clostridum difficile in US health care facility inpatients, 2008. Am J Infect Control 2009; 37:263-270
39. Zilberberg MD, Shorr AF, Kollef MH: Increase in adult Clostridium difficile-related hospitalizations and case fatality rate, United States, 2000-2005. Emerg Infect Dis 2008; 14:929-931
40. Kenneally C, Rosini JM, Skrupky LP, et al: Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting. Chest 2007; 132:418-424
41. Aboudola S, Kotloff KL, Kyne L, et al: Clos-tridium difficile vaccine and serum immu-noglobulin G antibody response to toxin A. Infect Immun 2003; 71:1608-1610
42. Zar FA, Bakkanagari SR, Moorthi KM, et al: A comparison of vancomycin and metroni-dazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45: 3032-3037
43. Kyne L, Warny M, Qamar A, et al: Association between antibody response to toxin A and protection against recurrent Clostrid-ium difficile diarrhea. Lancet 2001; 357: 189-193
44. McDonald LC, Killgore GE, Thompson A, et al: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-2441
45. Pepin J, Valiquette L, Cossette CL: Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173:1037-1042
46. Loo VG, Poirier L, Miller MA, et al: A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-2449
47. Pepin J, Valiquette L, Alary M-E, et al: Clos-tridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. CMAJ 2004; 171:466-472
48. Labbé AC, Poirier L, Maccannell D, et al: Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Che-mother 2008; 52:3180-3187
49. McEllistrem MC, Carman RJ, Gerding DN, et al: A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 2005; 40:265-272
50. Barbut F, Decre D, Lalande V, et al: Clinical features of Clostridium difficile-associated diarrhoeae due to binary toxin (actin-specific ADP-ribosyl transferase)-producing strains. J Med Microbiol 2005; 54:181-185
51. Lavallée C, Laufer B, Pépin J, et al: Fatal Clostridium difficile enteritis caused by the BI/NAP1/027 strain: A case series of ileal C. difficile infections. Clin Microbiol Infect 2009; 15:1093-1099
52. Louie T, Gerson M, Grimard D, et al: Results of a phase III trial comparing tol-evamar, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhea (CDAD). In: Proceedings of the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. September 17-20, 2007, Chicago
53. Dallal RM, Harbrecht BG, Boujoukas AJ, et al: Fulminant Clostridium difficile: An underappreciated and increasing cause of death and complications. Ann Surg 2002; 235:363-372
54. Dubberke ER, Reske KA, Yan Y, et al: Clos-tridium difficile-associated disease in a setting of endemicity: Identification of novel risk factors. Clin Infect Dis 2007; 45: 1543-1549
55. Cunningham R, Dial S: Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea? J Hosp Infect 2008; 70:1-6
56. Dial S, Alrasadi K, Manoukian C, et al: Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: Cohort and case-control studies. CMAJ 2004; 171:33-38
57. Rouphael NG, O'Donnell JA, Bhatnagar J, et al: Clostridium difficile-associated diarrhea: An emerging threat to pregnant women. Am J Obstet Gynecol 2008; 198:635.e1-6
58. Sunenshine RH, McDonald LC: Clostridium difficile-associated disease: New challenges from an established pathogen. Cleve Clin J Med 2006; 73:187-197
59. Bignardi GE: Risk factors for Clostridium difficile infection. J Hosp Infect 1998; 40: 1-15
60. Pepin J, Saheb N, Coulombe MA, et al: Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: A cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41:1254-1260
61. Brett S: Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness. Crit Care 2005; 9:45-50
62. Wilson KH, Sheagren JN, Freter R: Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis 1985; 151: 355-361
63. Yokohama S, Aoshima M, Asama T, et al: Clostridium difficile-associated enteric disease after percutaneous endoscopic gastros-tomy. J Gastroenetrol 2009; 44:121-125
64. Bliss DZ, Johnson S, Savik K, et al: Acquisition of Clostridium difficile and Clostrid-ium difficile-associated diarrhea in hospitalized patients receiving tube feedings. Ann Intern Med 1998; 129:1012-1019
65. Lawrence SJ, Puzniak LA, Shadel BN, et al: Clostridium difficile in the intensive care unit: Epidemiology, costs and colonization pressure. Infect Control Hosp Epidemiol 2007; 28:123-130
66. Asha NJ, Tompkins D, Wilcox MH: Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staph-ylococcus aureus. J Clin Microbiol 2006; 44:2785-2791
67. Ticehurst JR, Aird DZ, Dam LM, et al: Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Mi-crobiol 2006; 44:1145-1149
68. Stamper PD, Alcabasa R, Aird D, et al: Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cy-totoxicity assay and toxigenic culture for direct detection of toxin-producing Clos-tridium difficile in clinical samples. J Clin Microbiol 2009; 47:373-378
69. Dubberke ER, Gerding DN, Classen D, et al: Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29:S81-S92
70. Larson HE, Borriello SP: Quantitative study of antibiotic-induced susceptibility to Clos-tridium difficile enterocecitis in hamsters. Antimicrob Agents Chemother 1990; 34: 1348-1353
71. McFarland LV, Mulligan ME, Kwok RYY, et al: Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204-210
72. Clabots CR, Johnson S, Olson MM, et al: Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166:566-567
73. Kim KH, Fekety R, Batts DH, et al: isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143:42-50 (Pubitemid 11152596)
74. Wilcox MH, Fawley WN: Hospital disinfectants and spore formation by Clostridium difficile. Lancet 2000; 356:1324
75. Mayfield JL, Lee T, Miller J, et al: Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000; 31:995-1000
76. Rao GG, Jeanes A, Osman M, et al: Marketing hand hygiene in hospitals\a case study. J Hosp Infect 2002; 50:42-47
77. Gordin FM, Schultz ME, Huber RA, et al: Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol 2005; 26:650-653
78. Boyce JM, Ligi C, Kohan C, et al: Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 2006; 27:479-483
79. Rupp ME, Fitzgerald T, Puumala S, et al: Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units. Infect Control Hosp Epidemiol 2008; 29:8-15
80. Vernaz N, Sax H, Pittet D, et al: Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Che-mother 2008; 62:601-607
81. Kaier K, Hagist C, Frank U, et al: Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial me-thicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 2009; 30: 346-353
82. Fowler S, Webber A, Cooper BS, et al: Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: A controlled interrupted time series. J Antimicrob Chemother 2007; 59: 990-995
83. Valiquette L, Cossette B, Garant M-P, et al: Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007; 45:S112-S121
84. Climo MW, Israel DS, Wong ES, et al: Hospital-wide restriction of clindamycin: Effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 1998; 128:989-995
85. Chambers HF: Bacterial and chlamydial infections. In: Current Medical Diagnosis & Treatment. 47th Edition. McPhee SJ, Pa-padakis MA, Tierney LM (Eds). New York, McGraw-Hill, 2008, pp 1250-1252
86. Linam WM, Gerber MA: Changing epidemiology and prevention of Salmonella infections. Pediatr Infect Dis J 2007; 26:747-748
87. Peques DA, Ohl ME, Miller SI: Salmonella species including Salmonella typhi. In: Principles and Practice of Infectious Diseases. Sixth Edition. Mandell GL, Bennett JE, Dolin R (Eds). Philadelphia, Elsevier Churchill Livingstone, 2005, pp 2636-2654
88. Coburn B, Grassl GA, Finlay BB: Salmonella, the host, disease: A brief review. Immunol Cell Biol Feb-Mar 2007; 85:112-118
89. Jain S, Bidol SA, Austin JL, et al: Multistate outbreak of Salmonella typhimurium and Salmonella Stpaul infections associated with unpasteurized orange juice\United States 2005. Clin Infect Dis 2009; 48: 1065-1071
90. Levine WC, Smart JF, Archer DL, et al: Foodborne disease outbreaks in nursing homes. JAMA 1991; 266:2105-2109
91. Guallar C, Ariza J, Dominguez A, et al: An insidious nosocomial outbreak due to Salmonella enteritidis. Infect Control Hosp Epidemiol 2004; 25:10-15
92. Valdez JM, Scheinberg P, Young NS, et al: Infections in patients with aplastic anemia. Semin Hematol 2009; 46:269-276
93. Sirinavin S, Garner P: Antibiotics for treating salmonella gut infections. Cochrane Database Syst Rev 2000; CD001167
94. Huehn S, Malorny B: DNA microarray for Salmonella epidemiology. Methods Mol Biol 2009; 551:249-285
95. Velazquez FR, Matsra DO, Calva JJ, et al: Rotavirus infection in infants as protection against subsequent infection. N Engl J Med 1996; 335:1022-1028
96. Dagan R, Bar-David V, Sarov B, et al: Rota-virus diarrhea in Jewish and Bedouin children in the Negev region of Israel: Epidemiology and clinical aspects and possible role of malnutrition in severe illness. Pedi-atr Infect Dis J 1990; 9:314-321
97. Green KY, Sears JP, Taniguichi K, et al: Prediction of human rotavirus serotype by nucleic acid sequence analysis of VP7 protein gene. J Gen Virol 1988; 62:1819-1823
98. Absari SA, Springthorpe VS, Satto SA: Survival, vehicular spread of human rotavirus: Possible relationship to seasonal outbreaks. Rev Infect Dis 1991; 13:448-461
99. Raymond J, Aujard Y, the European Study Group: Nosocomial infections in pediatric patients: A European, multicenter prospective study. Infect Control Hosp Epidemiol 2000; 21:260-263
100. Gelber SE, Ratner AJ: Hospital-acquired viral pathogens in the neonatal intensive care unit. Semin Perinatol 2002; 26:346-356
101. Chandran A, Heinzen RR, Santosham M, et al: Nosocomial rotavirus infections: A systematic review. J Pediatr 2006; 149: 441-447
102. deZoysa I, Feachem RG: Interventions for the control of diarrhoeal diseases among young children: Rotavirus and cholera immunization. Bull World Health Organ 1985; 63:569-583
103. Kovacs A, Chan L, Hotrakitya C, et al: Ro-tavirus gastroenteritis: Clinical and laboratory features and use of Rotazyme test. Am J Dis Child 1987; 141:161-166
104. Rodriguez WJ, Kim HW, Arrobio JO, et al: Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children. J Pediatr 1977; 91:188-193
105. Saulsbury FT, Winkelstein JA, Yolken RH: Chronic rotavirus infection in immunodeficiency. J Pediatr 1980; 97:61-65
106. Doein GV, Hermann JE, Henderson P, et al: Detection of rotavirus with a new polyclonal antibody immunoassay (Rotalex): Comparison with a monoclonal antibody enzyme immunoassay. J Clin Microbiol 1986; 23: 222-269
107. Gouvea V, Glass RJ, Woods P, et al: Poly-merase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990; 28: 276-282
108. Gentsch JR, Glass RI, Woods P, et al: Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Micro-biol 1992; 30:1365-1373
109. Estes MK, Graham DY, Smith EM, et al: Rotavirus stability and inactivation. J Gen Virol 1979; 43:403-409
110. Lloyd-Evans N, Springthorpe VS, Sattar SA: Chemical disinfection of human rotavirus-contaminated inanimate surfaces. J Hyg (Lond) 1986; 97:163-173
111. Ward RL, Bernstein DI, Knowlton DR, et al: Prevention of surface-to-human transmission of rotavirus by treatment with disinfectant spray. J Clin Microbiol 1991; 29: 1991-1996
112. Mead PS, Slutsker L, Dietz V, et al: Food-related illness and death in the United States. Emerg Infect Dis 1999; 5:607-625
113. Glass RI, Noel J, Ando T, et al: The epidemiology of enteric caliciviruses from humans: A reassessment using new diagnostics. J Infect Dis 2000; 181(Suppl 2): S254-S261
114. Chadwick PR, McCann R: Transmission of a small, round structured virus by vomiting during a hospital outbreak of gastroenteritis. J Hosp Infect 1994; 26:251-259
115. Patterson W, Haswell P, Fryers PT, et al: Outbreak of small round structured virus gastroenteritis arose after kitchen assistant vomited. Commun Dis Rep CDR Rev 1997; 7:R101-R103
116. Khanna N, Goldenberger D, Graber P, et al: Gastroenteritis outbreak with norovirus in a Swiss university hospital with a newly identified virus strain. J Hosp Infect 2003; 55:131-136
117. Sakuma Y, Chiba S, Kogasaka R, et al: Prevalence of antibody to human calicivirus in general population of northern Japan. J Med Virol 1981; 7:221-225
118. Koo HL, Ajami NJ, Jiang Z-D, et al: A nos-ocomial outbreak of norovirus infection masquerading as Clostridium difficile infection. Clin Infect Dis 2009; 48:e75-e77
119. Martin AJ, Collins CJ, Ruddy R, et al: Simultaneous control of norovirus and Clos-tridium difficile outbreaks due to enhanced infection prevention and control measures. J Hosp Infect 2008; 68:180-181
120. Jiang X, Wang J, Estes MK: Characterization of SRSVs using RT-PCR and a new antigen ELISA. Arch Virol 1995; 140: 363-374
121. Richards AF, Lopman B, Gunn A, et al: Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces. J Clin Virol 2003; 26:109-115
122. Kilgore PE, Belay ED, Hamlin DM, et al: A university outbreak of gastroenteritis due to a small round-structured virus. Application of molecular diagnostics to identify the eti-ologic agent and patterns of transmission. J Infect Dis 1996; 173:787-793
123. Gary GW, Anderson LJ, Keswick BH, et al: Norwalk virus antigen and antibody response in an adult volunteer study. J Clin Microbiol 1987; 25:2001-2003
124. Brinker JP, Blacklow NR, Jiang X, et al: Detection of Norwalk virus and other geno-group 1 caliciviruses by a monoclonal antibody, recombinant antigen-based immuno-globin M capture assay. J Clin Microbiol 1998; 36:1064-1069
125. Marks PJ, Vipond IB, Regan FM, et al: A school outbreak of Norwalk-like virus: Evidence for airborne transmission. Epidemiol Infect 2003; 131:727-736
126. Amin OM: Seasonal prevalence of intestinal parasites in the United States during 2000. Am J Trop Med Hyg 2002; 66:799-803
127. MacKenzie WR, Schell WL, Blair KA, et al: Massive outbreak of waterborne Cryptospo-ridium infection in Milwaukee, Wisconsin: Recurrence of illness and risk of secondary transmission. Clin Infect Dis 1995; 21: 57-62
128. Collier CA, Miller AR, Meyers DJ: Crypto-sporidiosis after bone marrow transplantation: Person-to-person transmission and treatment with spiramycin. Ann Intern Med 1984; 101:206-206
129. Hunter PR, Nichols G: Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 2002; 15:145-154
130. Navarrete S, Stetler HC, Avila C, et al: An outbreak of Cryptosporidium diarrhea in a pediatric hospital. Pediatr Infect Dis 1991; 10:248-250
131. Koch KL, Phillips DJ, Aber RC, et al: Cryp-tosporidiosis in hospital personnel. Evidence for person-to-person transmission. Ann Intern Med 1985; 102:593-596
132. Bruce BB, Blass MA, Blumberg HM, et al: Risk of Cryptosporidium parvum transmission between hospital roommates. Clin Infect Dis 2000; 31:947-950
133. Chappell CL, Okhuysen PC, Sterling CR, et al: Cryptosporidium parvum: Intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis 1996; 173: 232-236
134. Newman RD, Seras CL, Moore SR, et al: Longitudinal study of Cryptosporidium infection in children in northeastern Brazil. J Infect Dis 1999; 180:167-175
135. Kim LS, Hadley WK, Stansell J, et al: Declining prevalence of cryptosporidiosis in San Francisco. Clin Infect Dis 1998; 27: 655-656
136. Weber R, Bryan R, Bishop H, et al: Threshold for detection of Cryptospo-ridium oocysts in human stool specimens: Evidence for low sensitivity of current diagnostic methods. J Clin Microbiol 1991; 29:963-965
137. Janoff EN, Mead PS, Mead JR, et al: Endemic Cryptosporidium and Giardia lam-blia infections in a Thai orphanage. Am J Trop Med Hyg 1990; 43:248-256
138. Dagan R, Fraser D, El-On J, et al: Evaluation of an enzyme immunoassay for the detection of Cryptosporidium spp. in stool specimens from infants and young children in field studies. Am J Trop Med Hyg 1995; 52:134-138
139. Centers for Disease Control and Prevention (CDC): Manufacturer's recall of rapid assay kits based on false positive Cryptosporidium antigen tests\Wisconsin, 2001-2002. MMWR Morb Mortal Wkly Rep 2002; 51:189
140. Balatbat AB, Jordan GW, Tang YJ, et al: Detection of Cryptosporidium parvum DNA in human feces by nested PCR. J Clin Mi-crobiol 1996; 34:1769-1772
141. Carpenter C, Fayer R, Trout J, et al: Chlorine disinfection of recreational water for Cryptosporidium parvum. Emerg Infect Dis 1999; 5:579-584
142. Fayer R: Effects of sodium hypochlorite exposure on infectivity of Cryptosporidium parvum oocysts for neonatal BALB/c mice. Appl Environ Microbiol 1995; 61:844-846
143. Weir SC, Pokorny NJ, Carreno RA, et al: Efficacy of common laboratory disinfectants on the infectivity of Cryptosporidium par-vum oocysts in cell culture. Appl Environ Microbiol 2002; 68:2576-2579
144. Kopach-Konrad R, Lawley M, Criswell M, et al: Applying systems engineering principles in improving health care delivery. J Gen Intern Med 2007; 22(Suppl 3):431-437
145. Proctor P, Compton WD, Grossma J, et al: Building a Better Delivery System: A New Engineering/Health Care Partnership, Committee on Engineering and the Health Care System. Washington, DC, National Academy of Engineering and Institute of Medicine, National Academy Press, 2005
146. Starfield B: Deficiencies in US medical care. JAMA 2000; 284:2184-2185